Dopaminergic stimulation of estrogen receptor binding in vivo: a reexamination.
Woolley
D E
DE
University of California, Davis 95616.
Hope
W G
WG
Thompson-Reece
M A
MA
Gietzen
D W
DW
Conway
S B
SB
D000315:Adrenalectomy; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001921:Brain / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure; D001971:Bromocriptine / Q000494:pharmacology; D002462:Cell Membrane / Q000378:metabolism; D002467:Cell Nucleus / Q000378:metabolism; D004050:Ditiocarb / Q000494:pharmacology; D004298:Dopamine / Q000502:physiology*; D004958:Estradiol / Q000378:metabolism; D005260:Female; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure; D007700:Kinetics; D008787:Metoclopramide / Q000494:pharmacology; D010052:Ovariectomy; D010903:Pituitary Gland, Anterior / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure; D051381:Rats; D017447:Receptors, Dopamine D1 / Q000502:physiology; D017448:Receptors, Dopamine D2 / Q000502:physiology; D011960:Receptors, Estrogen / Q000378:metabolism*
D017447:Receptors, Dopamine D1; D017448:Receptors, Dopamine D2; D011960:Receptors, Estrogen; D001971:Bromocriptine; D004958:Estradiol; D004050:Ditiocarb; D008787:Metoclopramide; D001058:Apomorphine; D004298:Dopamine